-
Freya Pharma Solutions Announces Launch of Phase II Clinical Dose-Response Study testing its LybridoTM Concept Targeting Female Sexual Dysfunction
04 Aug 2025 13:40 GMT
… . FSIAD is the clustering of Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder …
-
FDA updates in urology: July 2025
02 Aug 2025 02:48 GMT
… cancer (NMIBC), a medication for hypoactive sexual desire disorder (HSDD), and more.
Stay informed … of flibanserin (Addyi) to treat hypoactive sexual desire disorder (HSDD) in postmenopausal women. Safety …
-
Top 5 women's health headlines you missed in July 2025
01 Aug 2025 19:49 GMT
… ) use to postmenopausal women with hypoactive sexual desire disorder (HSDD).
Flibanserin is currently the …
-
Top in women’s health: Treating hypoactive sexual desire disorder; addressing PCOS needs
10 Oct 2024 21:04 GMT
… treat hypoactive sexual desire disorder in premenopausal women.
Many midlife women experience hypoactive sexual desire disorder, … to treat hypoactive sexual desire disorder
Many midlife women experience hypoactive sexual desire disorder, impacting both …
-
Balance between excitement, inhibition key to treat hypoactive sexual desire disorder
01 Oct 2024 16:24 GMT
…
CHICAGO — Many midlife women experience hypoactive sexual desire disorder, impacting both partner relationships and … to reduce their inhibition.”
Treating hypoactive sexual desire disorder
Hypoactive sexual desire disorder can be treated with psychotherapy …
-
Contemporary OB/GYN week in review: HSDD treatment, PAS guidelines, and more
25 Jul 2025 23:30 GMT
… covered topics ranging from postmenopausal hypoactive sexual desire disorder treatment to a new diagnostic … , highlighting a landmark in managing hypoactive sexual desire disorder (HSDD). No other FDA treatments …
-
From Botox To Better Sex: How Med-Spas Are Expanding Beyond Aesthetics With Addyi
25 Jul 2025 09:03 GMT
… Administration in 2015 to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. Last …
-
FDA Grants Fast Track Designation for Sprout's Flibanserin to Treat HSDD in Postmenopausal Women
24 Jul 2025 23:46 GMT
… to include postmenopausal women with hypoactive sexual desire disorder (HSDD). Flibanserin, marketed as Addyi … first and only pill for hypoactive sexual desire disorder. News release. Sprout Pharmaceuticals. September …
-
FDA grants priority review to expanded indication of flibanserin in HSDD
24 Jul 2025 22:06 GMT
… (Addyi, 100 mg) to treat hypoactive sexual desire disorder (HSDD) in postmenopausal women, Sprout …
-
FDA grants Priority Review to flibanserin for treating postmenopausal HSDD
24 Jul 2025 15:42 GMT
… , highlighting a landmark in managing hypoactive sexual desire disorder (HSDD). No other FDA treatments …
About
© 1995-2025